#None #Drug Development #Xtalks Webinar #Impurity Control

Upcoming Webinar on Residual Reagents in Drug Development

Xtalks is hosting a complimentary webinar aimed at educating participants about the crucial aspects of residual reagents and impurities in the field of drug development. Scheduled for October 13, 2026, at 1pm EDT, this informative session will feature expert speakers from BA Sciences, including Dr. Alaknanda Mishra and Mr. Ramakrishna Battula.

During the webinar, attendees will have the opportunity to delve into the identification, assessment, and control of residual reagents and impurities that can compromise both drug safety and effectiveness. The featured discussions will focus on risk-based analytical strategies and practices tailored for small molecules, biologics, and advanced therapeutic solutions.

As participants explore the complexities surrounding impurity control, they will learn about implementing fit-for-purpose assays, which are fundamental in optimizing processes and conducting thorough release testing. The session will also highlight how impurity control strategies can evolve based on the accumulation of process and product knowledge over time. Understanding these principles is essential for maintaining the integrity and compliance of drug development initiatives.

Importance of Controlling Residual Reagents

Residual reagents and impurities pose significant threats across various stages of drug development. They can affect the safety, efficacy, and regulatory approval of both small-molecule drugs and biologics. To effectively manage these risks, a strategic approach that interlinks process comprehension, analytical method refinement, and suitable specification settings is crucial.

The webinar will present practical methods for identifying the most critical residuals or impurities. Participants will gain insights into assessing their potential impact and will learn to develop suitable assays that support optimization efforts throughout the entire development cycle. By tailoring analytical strategies according to the nature and risk profile of specific impurities, development teams can collect meaningful data to steer quality and safety decisions.

Advancements in Analytical Techniques

In the dynamic sphere of pharmaceutical development, the integration of sensitive and selective analytical platforms is increasingly important. This enables a lifecycle-based approach to control strategies that foster robust, compliant, and scalable drug manufacturing processes. Throughout the webinar, the discussion will touch upon how testing requirements and control measures may shift as deeper insights into the production processes and products are obtained.

For those interested in navigating the complex landscape of drug development and impurity management, this webinar thirst for knowledge is invaluable. Practical insights shared by experienced professionals will equip attendees with tools and techniques to enhance their understanding and application in their respective projects.

Registration Details

To participate in this essential webinar, register at Xtalks' official website. It's a great opportunity for professionals looking to expand their knowledge, stay updated on industry practices, and engage in discussions that can shape the future of pharmaceutical development.

About Xtalks

Xtalks is powered by Honeycomb Worldwide Inc. and is dedicated to empowering life science professionals by providing trusted knowledge and collaborative insights that drive advancements in pharma, biotech, medtech, and healthcare. Join the Xtalks community to stay connected with the latest developments and insights in the life sciences sector. With thousands of professionals relying on Xtalks each year, this platform serves as a pivotal resource for those navigating an ever-evolving industry landscape.

For more information regarding this webinar and Xtalks' offerings, visit www.xtalks.com.